1887

Chapter 16 : Immunity to Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Immunity to Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap16-1.gif /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap16-2.gif

Abstract:

This chapter outlines present knowledge on the immune mechanisms operating against cholera based on studies of experimental animals infected with as well as of humans living in areas where cholera is endemic or convalescing from cholera disease. Owing to the critical role of cholera toxin (CT) in the pathogenesis of O1, much interest has been focused on the importance of antitoxic immunity for protection against cholera. Although lipopolysaccharide (LPS) apparently is responsible for much of the antibacterial cholera immunity induced, both by cholera vaccines and by infection, additional antigens, some of which may be expressed only during certain culture conditions or during growth in the intestine, may contribute to antibacterial protective immunity. The immune responses induced by clinical cholera in humans appear to be very efficient in providing prolonged protective immunity against subsequent infection with O1 bacteria. Symptomatic or asymptomatic infections with in early childhood may result in partial or complete immunity to cholera disease or even infection. Studies of the incidence of diarrhea in breast-fed children also suggest a protective effect of antitoxic as well as antibacterial antibodies in milk against cholera. The protective role of these antibodies has been difficult to assess, e.g., by comparing diarrhea morbidity in breast-fed and bottle-fed children, owing to several confounding factors.

Citation: Svennerholm A, Jonson G, Holmgren J. 1994. Immunity to Infection, p 257-271. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch16

Key Concept Ranking

Outer Membrane Proteins
0.47830582
Small Intestine
0.44325867
Cell-Mediated Immune Response
0.4422138
Major Histocompatibility Complex
0.43666735
0.47830582
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Immunoblot showing the antibody response after infection with rough O1 (strain 57) against in vivo-grown (vivo) and in vitro-grown (vitro) classical vibrios (Cairo 48). Antigens (one of which was in vivo specific) evoking the strongest responses had molecular masses of 10 to 18 kDa (indicated by arrowheads). The strong reactivity with the 22-kDa area reflects the presence of antibodies cross-reacting with core LPS in both pre- and postimmune sera. Low-molecular-mass references from Bio-Rad are indicated (in kilo-daltons).

Citation: Svennerholm A, Jonson G, Holmgren J. 1994. Immunity to Infection, p 257-271. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch16
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818364.chap16
1. Ahren, C., et al. Unpublished data.
1a. Ahren, C.,, C. Wenneras,, J. Holmgren,, and A.M. Svennerholm. Intestinal antibody response after oral immunization with a prototype enterotoxigenic Escherichia coli vaccine. Vaccine 11:929934.
2. Attrldge, S. R.,, and D. Rowley. 1983. The role of the flagellum in adherence of Vibrio cholerae. J. Infect. Dis. 147:864872.
3. Attridge, S. R.,, and D. Rowley. 1983. Prophylactic significance of nonlipopolysaccharide antigens of Vibrio cholerae. J. Infect. Dis. 148:931939.
4. Baselski, V.,, R. Briggs,, and C. Parker. 1977. Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice. Infect. Immun. 15:704706.
5. Booth, B. A.,, M. Boesman-Finkelstein,, and R. A. Finkelstein. 1983. Vibrio cholerae soluble haemagglutinin/protease is a metalloenzyme. Infect. Immun. 42:639644.
6. Brandtzaeg, P.,, K. Bjerke,, T. S. Haltsensen,, M. Hvatum,, K. Rett,, P. Krajci,, D. Kvale,, R. Müller,, D. Wilsson,, R. O. Roynum,, H. Scott,, L. M. Sollid,, P. Thrane,, and K. Values,. 1990. Local immunity; the human mucosa in health and disease, p. 112. In T. MacDonald,, J. Challacombe,, and W. Bland (ed.), Advances in Mucosal Immunology. Kluwer, London.
7. Cash, R.,, S. Music,, J. Libonati,, M. Snyder,, R. Wenzel,, and B. Hornick. 1974. Response of man to infection with V. cholerae. I. Clinical, serologic and bacteriologic responses to a known inoculum. J. Infect. Dis. 129:4552.
8. Clemens, J. D.,, F. Van Loon,, D. A. Sack,, M. R. Rao,, F. Ahmed,, J. Chakraborty,, B. A. Kay,, M. R. Khan,, M. D. Yunus,, J. R. Harris,, A.-M. Svennerholm,, and J. Holmgren. 1991. Biotype as a determinant of the natural immunizing effect of V. cholerae O1: implications for vaccine development. J. Infect. Dis. 23:473479.
9. Czerkinsky, C.,, A.-M. Svennerholm,, M. Quiding,, R. Jonsson,, and J. Holmgren. 1991. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination in humans. Infect. Immun. 59:9961001.
10. De, S. N.,, and D. N. Chatterje. 1953. An experimental study of the mechanism of action of Vibrio cholerae on the intestinal mucous membrane. J. Pathol. Bacteriol. 46:559562.
11. Feeley, J. C.,, and E. J. Gangarosa,. 1980. Field trials of cholera toxin, p. 204210. In O. Ouchterlony,, and J. Holmgren (ed.), Cholera and related diarrhoeal diseases. 43rd Nobel Symposium, Stockholm, 1978. Karger, Basel.
12. Foo, E. S. A.,, and W. Chaicumpa. 1981. Protection against Vibrio cholerae infection afforded by fragments of anti-haemagglutinin. Southeast Asian J. Trop. Med. Public Health 12:506512.
13. Franzon, V. L.,, A. Barker, and R A. Manning. 1993. Nucleotide sequence encoding the mannose-fucose-resistant hemagglutinin of Vibrio cholerae O1 and construction of a mutant. Infect. Immun. 61:30323037.
14. Glass, R. I.,, S. Becker,, M. I. Huq,, B. J. Stoll,, M. U. Khan,, M. H. Merson,, J. V. Lee,, and R. E. Black. 1982. Endemic cholera in rural Bangladesh, 1966-1980. Am. J. Epidemiol. 116:959970.
15. Glass, R. I.,, A.-M. Svennerholm,, M. R. Khan,, S. Huda,, I. Huq,, and J. Holmgren. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151:236242.
16. Glass, R.,, A.-M. Svennerholm,, B. J. Stoll,, M. R. Khan,, K. M. B. Hossain,, M. I. Huq,, and J. Holmgren. 1983. Protection against cholera in breast-fed children by antibodies in breast milk. N. Engl. J. Med. 308:13891392.
17. Goldberg, M. B.,, V. J. DiRita,, and S. B. Calderwood. 1990. Identification of an iron-regulated virulence determinant in Vibrio cholerae, using TuphoA mutagenesis. Infect. Immun. 58:5560.
18. Hall, R. H.,, G. Losonsky,, A. P. D. Silveira,, R. K. Taylor,, J. J. Mekalanos,, N. D. Witham,, and M. M. Levine. 1991. Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera. Infect. Immun. 59:25082512.
19. Holmgren, J.,, J. Fryklund,, and H. Larsson. 1989. Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: a local immune mechanism? Scand. J. Immunol. 30:499503.
20. Holmgren, J.,, and N. Lycke,. 1986. Immune mechanisms of enteric infections, p. 922. In J. Holmgren,, A. Lindberg,, and R. Mdllby (ed.), Development of Vaccines and Drugs against Diarrhea. 11th Nobel Conference, Stockholm. Studentlitteratur, Lund, Sweden.
21. Holmgren, J.,, and A.-M. Svennerholm. 1983. Cholera and the immune response. Prog. Allergy 33:106112.
22. Holmgren, J.,, A.-M. Svennerholm,, L. Gothefors,, M. Jertborn,, and B. Stoll. 1988. Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamestic immunoglobulin antitoxin response to oral cholera B subunit vaccination. Infect. Immun. 56:230233.
23. Jansen, W. H.,, H. Gielen,, S. G. T. Rijpkema,, and P. A. M. Guinee. 1988. Priming and boosting of the rabbit intestinal immune system with live and killed, smooth and rough Vibrio cholerae cells. Microb. Pathog. 4:2126.
24. Jertborn, M.,, A.-M. Svennerholm,, and J. Holmgren. 1986. Saliva, breast milk and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 24:203209.
25. Jertborn, M.,, A.-M. Svennerholm,, and J. Holmgren. 1988. Five-year immunologic memory in Swedish volunteers after oral cholera vaccination. J. Infect. Dis. 157:374377.
25a. Jonson, G., et al. Unpublished data.
26. Jonson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1991. Epitope differences in toxin-coregulated pili produced by classical and El Tor Vibrio cholerae OX.Microb. Pathog. 11:179188.
27. Jonson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1991. Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microb. Pathog. 11:433441.
28. Jonson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1992. Expression of toxin-coregulated pilus in Vibrio cholerae O1 in vitro and in vivo, abstr. B-400, p. 92. Abstr. 92nd Gen. Meet. Am. Soc. Microbiol. 1992.
29. Jonson, G.,, J. Holmgren,, and A.-M. Svennerholm. 1992. Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo. Infect. Immun. 60:42784284.
30. Jonson, G.,, J. Sanchez,, and A.-M. Svennerholm. 1989. Expression and detection of different biotype-associated cell-bound haemoagglutinins of Vibrio cholerae O1. J. Gen. Microbiol. 135: 111120.
31. Jonson, G.,, A.-M. Svennerholm,, and J. Holmgren. 1989. Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture. Infect. Immun. 57:18091815.
32. Jonson, G.,, A.-M. Svennerholm,, and J. Holmgren. 1990. Expression of virulence factors by classical and El Tor Vibrio cholerae in vivo and in vitro. FEMS Microbiol. Ecol. 74:221228.
33. Kazemi, M.,, and R. Finkelstein. 1990. Study of epitopes of cholera enterotoxin related enterotoxins by checkerboard immunoblotting. Infect. Immun. 58:23522360.
34. Kusama, H.,, and J. P. Craig. 1970. Production of biologically active substances by two strains of Vibrio cholerae. Infect. Immun. 1:8087.
35. Lee, J.-Y.,, A. Boman,, S. Chuanxin,, M. Andersson,, H. Jornvall,, V. Mutt,, and H. G. Boman. 1989. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc. Natl. Acad. Sci. USA 86:91599162.
36. Levine, M. M.,, J. B. Kaper,, R. E. Black,, and M. L. Clements. 1983. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:510550.
37. Levine, M. M.,, J. G. Morris,, G. Losonsky,, E. Boedeker,, and B. Rowe,. 1986. Fimbriae (pili) adhesins as vaccines, p. 143145. In D. Lark (ed.). Protein-Carbohydrate Interactions in Biological Systems. Academic Press, London.
38. Lycke, N.,, and J. Holmgren. 1989. Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin. Infect. Immun. 57:11371141.
39. Lycke, N.,, U. Karlsson,, A. Sjolander,, and K.-E. Magnusson. 1991. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand. J. Immunol. 33:691698.
40. Lycke, N.,, and A.-M. Svennerholm,. 1990. Presentation of immunogens at the gut and other mucosal surfaces, p. 207227. In G. C. Woodrow, and M. M. Levine (ed.), New Generation Vaccines. Marcel Dekker, Basel.
41. Lycke, N.,, A.-M. Svennerholm,, and J. Holmgren. 1986. Strong biotype and serotype cross-protective antibacterial and antitoxic immunity in rabbits after cholera infection. Microb. Pathog. 1:361371.
42. Madara, J. L.,, and J. Stafford. 1989. Interferongamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83:724.
43. Manning, P. A.,, A. F. Imbesi,, and D. R. Haynes. 1982. Cell envelope proteins in Vibrio cholerae. FEBS Microbiol. Lett. 14:159166.
44. Mestecky, J.,, and J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153245.
45. Mosley, W. H. 1969. Vaccines and somatic antigens. The role of immunity in cholera. A review of epidemiological and serological studies. Tex. Rep. Biol. Med. 27(Suppl. 1):227241.
46. Mosley, W. H.,, W. E. Woodward,, K. M. A. Aziz,, M. A. S. M. Rhaman,, A. K. M. A. Chowdhury,, A. Ahmed,, and J. C. Feeley. 1970. The 1968-69 cholera vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. 7. Infect. Dis. 121:471479.
47. O'Mahony, S.,, E. Arranz,, J. R. Barton,, and A. Ferguson. 1990. Appraisal of gut lavage in the study of intestinal humoral immunity. Gut 31:13411344.
47a. Osek, J., et al. Unpublished data.
48. Osek, J.,, G. Jonson,, A.-M. Svennerholm,, and J. Holmgren. 1992. Enzyme-linked immunosorbent assay for determination of antibodies to Vibrio cholerae toxin-coregulated pili. APMIS 100:10271032.
49. Osek, J.,, A.-M. Svennerholm,, and J. Holmgren. 1992. Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili. Infect. Immun. 60:49614964.
50. Patel, P. P.,, C. F. Marrs,, J. S. Mattick,, W. W. Ruehl,, R. K. Taylor,, and M. Koomey. 1991. Shared antigenicity and immunogenicity of type 4 pilins expressed by Pseudomonas aeruginosa, Moraxella bovis, Neisseria gonorrhoeae, Dichelobacter nodosus, and Vibrio cholerae. Infect. Immun. 59:46744676.
51. Pierce, N. F. 1978. The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxoid and toxin in rats. J. Exp. Med. 148:195206.
52. Quiding, M.,, I. Nordstrom,, A. Kilander,, G. Andersson,, L.-A. Hanson,, J. Holmgren,, and C. Czerkinsky. 1991. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses, gamma-interferon production, and evokes local immunological memory. J. Clin. Invest. 88:143148.
53. Richardson, K.,, J. B. Kaper,, and M. M. Levine. 1989. Human immune response to V. cholerae O1 whole cells and isolated outer membrane antigens. Infect. Immun. 57:495501.
54. Sciortino, C. V. 1989. Protection against infection with V. cholerae by passive transfer of monoclonal antibodies to outer membrane antigens. J. Infect. Dis. 160:248252.
55. Sears, S. D.,, K. Richardson,, C. Young,, C. D. Parker,, and M. M. Levine. 1984. Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae. Infect. Immun. 44:439444.
56. Sengupta, D. K.,, T. K. Sengupta,, and A. C. Ghose. 1992. Major outer membrane proteins of Vibrio cholerae and their role in induction of protective immunity through inhibition of intestinal colonization. Infect. Immun. 60:48484855.
57. Sinha, V. B.,, A. Jacob,, R. Srivastava,, J. B. Kaper,, and B. S. Srivastava. 1993. Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection. Vaccine 11:372375.
58. Spira, W. M.,, R. B. Sack,, and J. L. Froelich. 1981. Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect. Immun. 32:739747.
59. Stroeher, U. W.,, L. E. Karageorgos,, R. Morona,, and P. Manning. 1992. Serotype conversion in Vibrio cholerae O1. Proc. Natl. Acad. Sci. USA 89:25662570.
60. Sun, D.,, D. M. Tillman,, T. N. Marion,, and R. K. Taylor. 1990. Production and characterization of monoclonal antibodies to the toxin coregulated pilus (TCP) of Vibrio cholerae that protect against experimental cholera in infant mice. Serodiagn. Immunother. Infect. Dis. 4:7381.
61. Svennerholm, A.-M., 1980. The nature of protective immunity in cholera, p. 171184. In Ö. Ouchterlony, and J. Holmgren (ed.), Cholera and Related Diarrheal Diseases. 43rd Nobel Symposium, Stockholm, 1978, Karger, Basel.
62. Svennerholm, A.-M.,, L. Gothefors,, D. A. Sack,, P. K., Bardhan,, and J. Holmgren. 1984. Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. Bull. W.H. O. 62:909918.
63. Svennerholm, A.-M.,, and J. Holmgren. 1976. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect. Immun. 13:735740.
64. Svennerholm, A.-M.,, and J. Holmgren,. 1992. Immunity to enterotoxin-producing bacteria, p. 227246. In T. T. MacDonald (ed.), Immunology of Gastrointestinal Disease, vol. 19. Kluwer Academic Publishers, London.
65. Svennerholm, A.-M.,, J. Holmgren,, R. Black,, and M. Levine. 1983. Serologic differentiation between antitoxin responses to infection with V. cholerae and enterotoxin-producing Escherichia coli. J. Infect. Dis. 147:514521.
66. Svennerholm, A.-M.,, M. Jertborn,, L. Gothefors,, A. M. M. M. Karim,, D. A. Sack,, and J. Holmgren. 1984. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149:884893.
67. Svennerholm, A.-M.,, G. Jonson,, and Y. Chang. 1991. A method for studies of an El Tor-associated antigen of Vibrio cholerae O1. FEMS Microbiol. Lett. 79:179186.
68. Svennerholm, A.-M.,, M. M. Levine,, and J. Holmgren. 1984. Weak serum and intestinal antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients. Infect. Immun. 45:792794.
68a. Svennerholm, A.-M.,, D. Taylor,, G. Johnson,, and C. K. English. Unpublished data.
69. Tagliabue, A.,, D. Boraschi,, D. F. Villa,, D. R. Keren,, G. H. Lowell,, R. Rappuoli,, and L. Nencioni. 1984. IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity and characterization of the effector cells. J. Immunol. 133:988992.
70. Taylor, R. K.,, V. L. Miller,, D. B. Furlong,, and J. J. Mekalanos. 1987. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc. Natl. Acad. Sci. USA 84:28332837.
71. Tokunaga, E.,, W. C., Cray, Jr.,, and N. F. Pierce. 1984. Compared colonizing and immunizing efficiency of toxinogenic (A+ B+) Vibrio cholerae and an A- B+ mutant (Texas Star-SR) studied in adult rabbits. Infect. Immun. 44:364369.
72. Wikstrom, M.,, G. Jonson,, and A.-M. Svennerholm. 1991. Production and characterization of monoclonal antibodies to Vibrio cholerae soluble hemagglutinin. APMIS 99:249256.
73. Yancey, R. J.,, D. L. Willis,, and L. J. Berry. 1979. Flagella-induced immunity against experimental cholera in adult rabbits. Infect. Immun. 25:220228.
74. Young, D. B.,, and D. A. Broadbent. 1982. Biochemical characterization of extracellular proteases from Vibrio cholerae. Infect. Immun. 37:875883.

Tables

Generic image for table
Table 2

Serum antibody responses to different antigens in Peruvians convalescing from clinical cholera ( )

Citation: Svennerholm A, Jonson G, Holmgren J. 1994. Immunity to Infection, p 257-271. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch16
Generic image for table
Table 1

Serum antibody responses in rabbits after intestinal infection with smooth and rough V. cholerae O1 and non-O1 V. cholerae

Citation: Svennerholm A, Jonson G, Holmgren J. 1994. Immunity to Infection, p 257-271. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch16

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error